rct
    2009

    Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS

    Hun L

    Published in Postgraduate Medicine

    Abstract

    Double-blind placebo-controlled trial of Bacillus coagulans GBI-30, 6086 in irritable bowel syndrome.

    Key Findings

    Bacillus coagulans GBI-30, 6086 significantly reduced abdominal pain and bloating scores versus placebo over 8 weeks in IBS patients.

    Conclusions

    A specific B. coagulans strain may relieve core IBS symptoms.

    Limitations

    Small single-centre trial, industry-funded, limited outcome set.

    Supplements Studied

    Bacillus coagulans GBI-30, 6086 significantly reduced abdominal pain and bloating scores versus placebo over 8 weeks in IBS patients.

    Related Health Concerns

    Bloating & Gas
    IBS (Irritable Bowel Syndrome)

    Study Details

    Year:2009
    Sample Size:44
    Duration:8 weeks
    Quality Score:5/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.